Skip to Main content Skip to Navigation
Master Thesis

Le rôle du pharmacien d’officine dans la prise en charge thérapeutique et dans la chimioprophylaxie du VIH

Abstract : Today, around the world, an estimated 38 million people are living with the human immunodeficiency virus (HIV). The fight against this virus is a global public health problem. Antiretrovirals (ARVs) constitute the therapeutic arsenal against HIV. Thanks to the progress in therapeutic management, 26 million people had access to antiretroviral therapy in 2019. These treatments do not cure HIV infection. However, people with HIV are now living longer and they can enjoy a good quality of life. The traditional model of battling HIV, based on condom use alone, has run out of steam. And it has brought up a new prevention approach: diversified prevention. This new strategy combines prevention campaigns, condom use, access to screening and access to ARV treatments. The pharmacist has his role to play in this new approach. He is the last link in the healthcare process and he is a local health professional. Therefore, he has an essential role in HIV prevention and awareness. The pharmacist can be an effective sender of prevention and screening messages. Pre-Exposure Prophylaxis (PrEP) is a diversified prevention tool. It consists of taking antiretrovirals, in people not infected with HIV, in order to prevent the risk of acquiring this virus. Many studies have shown the effectiveness of PrEP. However, many limitations and obstacles prevent its optimal use. New perspectives around PrEP may end its barriers.
Document type :
Master Thesis
Complete list of metadata
Contributor : UFR Santé UNICAEN Connect in order to contact the contributor
Submitted on : Monday, December 6, 2021 - 9:56:00 AM
Last modification on : Saturday, December 18, 2021 - 3:53:37 AM
Long-term archiving on: : Monday, March 7, 2022 - 6:18:05 PM


Files produced by the author(s)


  • HAL Id : dumas-03466650, version 1


Pauline Rossignol. Le rôle du pharmacien d’officine dans la prise en charge thérapeutique et dans la chimioprophylaxie du VIH. Sciences pharmaceutiques. 2021. ⟨dumas-03466650⟩



Record views


Files downloads